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ABSTRACT
The biological effect of oxidatively damaged RNA,
unlike oxidatively damaged DNA, has rarely been in-
vestigated, although it poses a threat to any living
cell. Here we report on the effect of the commonly
known RNA base-lesions 8-oxo-rG, 8-oxo-rA, -rC, -
rA, 5-HO-rC, 5-HO-rU and the RNA abasic site (rAS)
on ribosomal translation. To this end we have de-
veloped an in vitro translation assay based on the
mRNA display methodology. A short synthetic mRNA
construct containing the base lesion in a predefined
position of the open reading frame was 32P-labeled
at the 5′-end and equipped with a puromycin unit at
the 3′-end. Upon in vitro translation in rabbit retic-
ulocyte lysates, the encoded peptide chain is trans-
ferred to the puromycin unit and the products ana-
lyzed by gel electrophoresis. Alternatively, the un-
labeled mRNA construct was used and incubated
with 35S-methionine to prove peptide elongation of
the message. We find that all base-lesions interfere
substantially with ribosomal translation. We identi-
fied two classes, the first containing modifications
at the base coding edge (-rC, -rA and rAS) which
completely abolish peptide synthesis at the site of
modification, and the second consisting of 8-oxo-rG,
8-oxo-rA, 5-HO-rC and 5-HO-rU that significantly re-
tard full-length peptide synthesis, leading to some
abortive peptides at the site of modification.
INTRODUCTION
The integrity of nucleic acids is constantly challenged by
ubiquitous reactive oxygen and nitrogen species (ROS,
RNS) which are mainly produced endogenously by the mi-
tochondrial respiratory chain (NADPH oxidases (NOX),
and 5-lipoxygenases (LOX)), or originate from exogenous
sources like tobacco, drugs, xenobiotics and ionizing radi-
ation (1). These agents primarily oxidize the nucleic acid
bases and are thus a threat for the genetic information trans-
fer. While distinct repair mechanisms are present to main-
tain the integrity of the genome, the fate of oxidatively dam-
aged RNA is still largely unknown: so far, only in the case
of methylated RNA a repair mechanism could be identified
(2). Recently, high levels of oxidatively damaged RNA have
been closely linked to aging and to a still growing number
of neurodegenerative and other diseases (3). The data so far
suggest that RNA oxidation is an early event in these pro-
cesses, rather than merely the effect of cell decay (4,5).
Nucleobases can be either directly oxidized by ROS
or indirectly by oxidation products from polyunsatu-
rated fatty acids (PUFAs). For direct oxidation of nu-
cleic acids the main reactive oxygen species are sin-
glet oxygen (1O2) and the hydroxyl radical (•OH) that
can yield a large number of compounds in DNA (6,7)
and presumably also in RNA. Oxidized RNA nucleo-
sides isolated so far include 5-hydroxyuridine (5-HO-rU),
5-hydroxycytidine (5-HO-rC), 8-oxo-7,8-dihydroguanosine
(8-oxo-rG) and 8-oxo-7,8-dihydroadenosine (8-oxo-rA)
(8,9). In parallel to the formation of 8-oxo purines, in-
termediate 8-hydroxy-7,8-dihydro-7-yl radicals that form
by the abstraction of hydroxyl radicals on C8 can
also undergo single electron reduction to form 2,6-
diamino-4-hydroxy-5-formamidopyrimidine (FapyG) and
4,6-diamino-5-formamidopyrimidine nucleosides (FapyA),
respectively (10). Both lesions have recently been quantified
in the analysis of RNA damage in Alzheimer’s disease pa-
tients. It can therefore be assumed that they are also present
in the pool of oxidatively damaged RNA (11). In addition,
Akaike et al. showed that nitric oxide and peroxynitrite ac-
celerate mutation of RNA viruses in vitro as well as in vivo
(12). Presumably, this effect is based on themutagenic prop-
erties of 8-oxo-rG and 8-nitro-rG that are formed under
these RNS conditions (13). Nucleobases can also be alky-
lated by lipid peroxidation products: PUFAs are oxidized
enzymatically (lipoxygenases, cyclooxygenases) or by direct
abstraction of hydroxyl radicals to a complexmixture of hy-
droperoxides (14). Subsequent products have been shown
to yield a great number of adducts with nucleobases in
DNA (15). In particular 4,5-epoxy-2-decanal (EDE) and 4-
hydroperoxy-2-nonenal (HPNE) have been shown to yield
unsubstituted etheno adducts with dA, dG and dC.
In order to elucidate their potential mutagenic properties,
various oxidatively damaged nucleobases have been syn-
thetically incorporated into RNA and their coding prefer-
ences in templated primer extension reactions (PEX) by re-
verse transcriptases have been examined. These studies in-
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clude base lesions such as abasic sites (rAS) (16,17), 8-oxo-
rA (18), 8-oxo-rG (19), 5-HO-rU (20), 5-HO-rC (21), ε-rA
and ε-rC (22) (Figure 1). The findings suggest that some
of these oxidized bases change their native Watson–Crick
base-pairing selectivity. In the context ofmRNAs thismight
subsequently lead to the synthesis of modified proteins, as
was suggested earlier (23).
The possible impact of oxidative lesions on the trans-
lation machinery has only been addressed by a handful
of studies so far. Translation of oxidized firefly luciferase
mRNA (treated with H2O2/cytochrome c) in rabbit retic-
ulocyte lysate and transfected HEK-293 and PC-12 cells
showed that luciferase activity and detectable protein lev-
els decreased dramatically in all systems depending on the
oxidation level of the mRNA (24). Similar results were ob-
tained for the translation of oxidized enhanced green flu-
orescent protein mRNA in transfected HEK-293 cells. Ri-
bosome stalling on the transcript rather than the produc-
tion of truncated proteins (4) was observed in these cases. In
another study Tanaka et al. showed that translation of lu-
ciferase mRNA in reticulocyte lysate and in HEK-293 cells
led to increased levels of short polypeptides, independent
whether themRNAwas oxidized before translation (treated
with Fe/ascorbate/H2O2) or translation was performed un-
der oxidative conditions (in the presence of paraquat) (25).
The results indicate that the stability of oxidized mRNA is
comparable to that of non-oxidized mRNA and that oxi-
dized mRNA is in principal accepted for translation.
To understand the impact of mRNA base-lesions on a
molecular level we set out to study the translation of short
synthetic mRNAs with a series of well-defined single oxida-
tive lesions in predefined positions using the in vitro RNA
display system of Roberts and Szostak (26). In this system,
the synthesized peptide is covalently linked to the encoding
mRNA bearing a puromycin unit on the 3′-end of the tem-
plate. This system allows the investigation of the effect of
single oxidative lesions on translation and the direct analy-
sis of the fusion products by gel electrophoresis.
MATERIALS AND METHODS
Oligonucleotide synthesis and purification
Unmodified DNA and RNA oligonucleotides were pur-
chased from Microsynth (Balgach, Switzerland) and
HPLC- or PAGE-purified where necessary. Modified olig-
oribonucleotides were synthesized using the known 2′-O-
TBDMS protected phosphoramidite building blocks for
the base-oxidized nucleosides of Figure 1 (18,20,22,27,28).
In the case of 8-oxo-rG the synthesis of the phospho-
ramidite building block (19) was slightly changed (see the
Supplementary Information). Natural 2′-O-TBDMS pro-
tected RNA phosphoramidites and CPG solid supports
were from GlenResearch or AZCO. Puromycin solid sup-
port and spacer phosphoramidite 9 were purchased from
GlenResearch. Syntheses were performed on a 1.3-mole
scale on a Pharmacia Gene Assembler Plus DNA synthe-
sizer following standard phosphoramidite protocols with
5-(ethylthio)-1H-tetrazole (0.25 M in acetonitrile) as the
activator and coupling times of 12 min. Table 1 gives an
overview over all oligoribonucleotides used in this study.
Modified oligoribonucleotides were deprotected using
the conditions reported in Table 1. Solid supports were fil-
tered off and washed with water and solutions were evapo-
rated to dryness at room temperature in a Speedvac evap-
orator. The resulting pellets were further dried by addition
and evaporation of dry ethanol. The obtained product was
dissolved in anhydrous DMSO (100 l) and neat triethy-
lamine trihydrofluoride (125 l) was added. After shaking
at 25◦C for 24 h, an aqueous solution of NaOAc (3 M, pH
= 5.2, 25 l) and n-butanol (1 ml) were added and the mix-
ture was chilled on dry ice for 45 min. After centrifugation
for 20 min in an Eppendorf centrifuge the supernatant was
discarded, the pellet washed twice with cold ethanol (80%,
1 ml) and dried under high vacuum at room temperature,
yielding the crude oligonucleotides.
Oligoribonucleotides were purified on a preparative
20% denaturing polyacrylamide gel, product bands elec-
troeluted with an Elutrap electroelution system (Schle-
icher & Schuell) and desalted using Amicon ultra 0.5
filters (MWCO 3 KDa, Millipore). Oligonucleotide con-
centrations were determined using a NanoDrop ND-
100 UV/Vis spectrophotometer (NanoDrop Technologies,
Inc.). Stock solutions were made from DEPC treated H2O.
Oligoribonucleotides containing (2-nitrophenyl)ethyl or 2-
nitrobenzyl protections (rAS and 5-HO-rC) were depro-
tected with UV-light at wavelengths above 300 nm just be-
fore the translation assays (see below).
Splint ligation
In order to create the translation templates, each RNA se-
quence 1–11 was fused to the 5′-phosphorylated end of the
linker sequence (29) using the splint oligonucleotide and T4
DNA ligase (30). Forty two microliter of linker sequence
(100 M) was mixed with 28 l of 10X ligase buffer (300-
mM Tris-HCl, 100-mMMgCl2, 100-mMDTT and 10-mM
adenosine triphosphate (ATP), pH 7.8), 140l of water and
42l of T4 polynucleotide kinase (Fermentas). Themixture
was incubated at 30◦C for 30min, 75◦C for 10min and 20◦C
for 10 min. Sixty three microliter of the splint (100 M) and
42 l of an RNA sequence (100 M) were added, and the
solution was incubated at 80◦C for 2 min and 30◦C for 20
min. Fourteen microliter of 10X ligase buffer, 14 l of T4
DNA ligase and 40 l of PEG were added, and the mixture
was incubated at 30◦C for 3 h and 70◦C for 5 min.
The ligation products were purified on preparative 20%
denaturing polyacrylamide gels, electroeluted with an Elu-
trap electroelution system (Schleicher & Schuell) and de-
salted using Amicon ultra 0.5 filters (MWCO 3KDa,Milli-
pore). The translation templateswere precipitated (100l of
water, 30 l of 3-M NaOAc and 1.2 ml of ethanol), washed
with 80% ethanol, dried and diluted in water. Oligonu-
cleotide concentrations were determined using a Nan-
oDrop ND-100 UV/Vis spectrophotometer (NanoDrop
Technologies, Inc.).
Labeling of the synthetic mRNAs
The splint ligation product was phosphorylated with [ -
32P]ATP (Hartmann Analytic) and T4 polynucleotide ki-
nase (Fermentas) as follows: template (30 pmol), [ -32P]-
ATP (60 mCi) and T4 PNK (10 U) were incubated in a total
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Figure 1. Structures of RNA lesions investigated: 8-oxo-7,8-dihydroadenosine (8-oxo-rA), 8-oxo-7,8-dihydroguanosine (8-oxo-rG), 5-hydroxycytidine (5-
HO-rC), 5-hydroxyuridine (5-HO-rU), 1,N6-ethenoadenosine (ε-rA), 3,N4-ethenocytidine (ε-rC) and abasic site (rAS); rib = ribose.
Table 1. DNA and RNA sequences used in this work and cleavage conditions
splint d(TTTTTTTTTTGATCAGTTTCTGTTC) a)
linker d(AAA AAA AAA AAA AAA AAA AAA-999-ACC-P) NH4OH/EtOH 3:1, 55◦C, 24 h
RNA1 r(GGG AGG ACG AAA UGG AAC AGA AAC UGA UC) a)
RNA2 r(GGG AGG ACG AAA UGG AAC AGA CAC UGA UC) a)
RNA3 r(GGG AGG ACG AAA UGG AAC AGA GAC UGA UC) a)
RNA4 r(GGG AGG ACG AAA UGG AAC AGA UAC UGA UC) a)
RNA5 r(GGG AGG ACG AAA UGG AAC AGA (-rA)AC UGA UC) NH4OH/EtOH 3:1, rt, 17 h
RNA6 r(GGG AGG ACG AAA UGG AAC AGA (5-HO-rU)AC UGA UC) NH4OH/EtOH 3:1, rt, 17 h
RNA7 r(GGG AGG ACG AAA UGG AAC AGA (8-oxo-G)AC UGA UC) NH4OH/EtOH 3:1, 0.25-M ethanethiol, 55◦C, 17 h
RNA8 r(GGG AGG ACG AAA UGG AAC AGA (5-HO-rC)AC UGA UC) NH4OH/EtOH 3:1, 55◦C, 17 h
RNA9 r(GGG AGG ACG AAA UGG AAC AGA (8-oxo-A)AC UGA UC) MeNH2 (40% in H2O)/MeNH2 (33% in EtOH) 1:1, rt, 17 h
RNA10 r(GGG AGG ACG AAA UGG AAC AGA (-rC)AC UGA UC) NH4OH/EtOH 3:1, rt, 17 h
RNA11 r(GGG AGG ACG AAA UGG AAC AGA (rAS)AC UGA UC) NH4OH/EtOH 3:1, 55◦C, 17 h
a) Purchased fromMicrosynth, Balgach, Switzerland. P = puromycin, 9 = triethylene glycol spacer. Bold letters refer to the position of the modifications.
volume of 20 l at 37◦C for 30 min in T4 PNK buffer (50-
mM Tris-HCl, 10-mM MgCl2, 5-mM DTT, 0.1-mM sper-
midine, 0.1-mM ethylenediaminetetraacetic acid (EDTA),
pH 7.6). T4 PNK was inactivated by heating the sample to
80◦C for 2 min. The labeled oligonucleotide was purified
on a preparative 20% denaturing polyacrylamide minigel.
Product bands were cut, crushed and suspended in elution
buffer (0.5-MTris-HCl, 0.1% sodium dodecyl sulphate, 0.1-
mM Na2EDTA, 1-mM MgCl2, pH 7). To each crushed
band 1 ml of elution buffer was added and the mixtures
were frozen and melted to room temperature three times.
The mixtures were incubated overnight at room temper-
ature. The supernatant was recovered after centrifugation
and the solid was washedwith elution buffer. Solutions con-
taining oligonucleotides were concentrated with n-butanol
and precipitated with ethanol and 3-M NaOAc. Oligonu-
cleotides were dissolved in DEPC treated water and used
directly for translation assays.
Translation assays
Translation assays were performed following the protocol
developed by Roberts and Szostak (26) using commercially
available rabbit reticulocyte lysates (Flexi R© Rabbit Retic-
ulocyte Lysate System, Promega). Before translation, the
RNA template was denatured for 3 min at 65◦C and left for
20 min on ice. In the case of abasic site or 5-HO-rC contain-
ing oligonucleotides, the photocleavable protecting groups
were removed just before the assay by irradiation for 1 h us-
ing a slide projector (17,21). The translation mastermix was
prepared using stock solutions provided with the lysate as
follows: 33 l of lysate, 1 l of 1-mM amino acid mixture,
0.5 l of 25-mMMg(AcO)2, 1 l of 2.5-MKCl, 1 l of 100-
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mM DTT, 1 l of RNasin (Promega), RNA template (20
pmol in 12 l) and 0.5 l of water. When [35S]-methionine
labeling was used, an amino acid mixture without methion-
ine was used, and 2l of [35S]-methionine (1200Ci/mmol at
10mCi/ml, Promega)was added. The systemwas incubated
for 90 min at 37◦C and for 40 min at 0◦C. Then, 8 l of 4-M
KCl and 5 l of 1-MMgCl2 were added and the system was
incubated for 1 h at room temperature and left overnight at
−20◦C. The mixture was diluted in gel loading buffer (98%
formamide, 0.05% xylene cyanol (FF), 0.05% bromophenol
blue), heated to 70◦C for 5 min and applied to a 10 or 20%
denaturing polyacrylamide gel. Radioactivity was detected
and quantified on a Storm 820 phosphorimager with Im-
ageQuant software (GE Healthcare).
RESULTS
Experimental setup
To determine the effect of an mRNA lesion on protein
biosynthesis we decided to develop an in vitro transla-
tion assay (Figure 2) based on the mRNA-display method
(26,29,31,32). In this method the encoded peptide becomes
covalently linked to the message at the end of translation
by a puromycin unit (P) that is attached via a DNA-linker
to the 3′-end of the message. Puromycin is a nucleoside
that mimics the aminoacyl end of tRNA and covalently
binds the nascent peptide by entering the P-site of the ri-
bosome (26). We reasoned that this method is superior to
standard translation assays without covalent attachment of
the peptide in view of expected difficulties in the isolation
of the small peptide out of the translation mixture. Fur-
thermore, the nucleic acid part in the translation product
enables easy analysis by polyacrylamide gel electrophore-
sis (PAGE) from which information on full length, partial
length or absence of an attached peptide should be visible
by differential gel shifts. 32P-labeling of the mRNA con-
struct before translation can be used to visualize the re-
action products. Alternatively, translation with unlabeled
mRNA in the presence 35S-methionine can be used to un-
ambiguously prove the covalent inclusion of the peptide.
To this end we designed short synthetic mRNA 29 mers
(Figure 2a) encoding 6 amino acids containing each of the
base-modifications depicted in Figure 1 in a predefined po-
sition (X). These mRNAs were then fused to a DNA-linker
consisting of 21 dA followed by three ethylene glycol units
and the dACCP domain via splinted ligation, leading to the
final transcription template.
Sequence design and synthesis
The assay is illustrated in Figure 2b and corresponds to a
modified sequence construct used in previous work (26).
The mRNA was designed bearing a ribosome binding site
at the 5′ end, followed by a start codon (AUG) and five
more codons. The linker sequence consisted of 21 dA units,
linked to three ethylene glycol spacers, a CAA sequence
and a puromycin unit. Spacers were introduced in order to
increase template flexibility and with this fusion efficiency
(29). The lesions were placed into the second position of
the fourth codon. Thus, read-through or abortion of pep-
tide synthesis was expected to be easily detectable by a shift
of the product band on an electrophoretic gel.
The synthesis of oligoribonucleotides containing the base
lesions was performed using standard RNA protocols. To
prevent degradation at the site of the base lesions, cleav-
age and deprotection conditions had to be optimized for
each lesion individually (see the Materials and Methods
section). Deprotected sequences were purified by PAGE,
electroeluted and desalted before use. Oligoribonucleotides
containing an abasic site or a 5-HO-rC unit, bearing a pho-
tocleavable protecting group, were additionally light depro-
tected directly before use.
Full-length mRNA constructs were obtained via splint
ligation (Figure 2). The efficiency of the ligation was mon-
itored by PAGE, and was estimated to be quantitative in
all cases (an example of a gel is included in the Supple-
mentary Information section). ThemRNA-puromycin con-
structs were again purified by PAGE and labeled with [ -
32P] ATP. Fusion translation experiments were carried out
as reported in the Materials and Methods section, using
rabbit reticulocyte lysate. The experiment was performed
in two phases, a translation phase followed by a peptide-
mRNA fusion phase induced by increasing the salt concen-
tration. Final mixtures were analyzed by 10% PAGE.
In order to study the efficiency of the translation assay, a
template using a natural rA unit at position X was used. As
shown in Figure 3, the product of the mRNA display assay
shows two main bands. The faster eluting band (a) can be
attributed to the non-translated template while the slower
moving band (b) was attributed to the template-peptide fu-
sion product.
We then tested the effect of the base lesion 5-HO-rC on
translation. As reported in a previous paper, this lesion
showed some unexpected thermal melting properties when
introduced into an RNA sequence (27). An mRNA con-
struct containing unmodified rC was used as a control. To
identify whether different pretreatments of the mRNA con-
struct had an effect on translation we performed the as-
say with 5-HO-rC that was base-deprotected either before
or after splint ligation and with and without heat treat-
ment. Since the 5-O-protected 5-HO-rC construct was any-
way available it was also tested. The results of the transla-
tion assay are depicted in Figure 4.
From entries 3–5 (Figure 4) it appears that translation
of a 5-HO-rC unit as compared to an rC unit (entry 1)
leads to an overall reduced translation efficiency. More im-
portantly, intermediates appear that correspond to fusion
products with aborted peptide sequences most likely at the
site of lesion. From comparison of entries 3–5 it becomes
clear that the appearance of truncated transcripts is inde-
pendent of the pretreatment of the mRNA construct before
translation. We see, however, differences in translation effi-
ciencies. The highest yields are obtained if the 5-HO-rC is
deprotected just before the translation assay. Interestingly,
if 5-O-protected 5-HO-rC was used (Figure 4, column 2),
translation proceeded to the fusion product without appar-
ent formation of intermediates. Obviously the introduction
of a bulky benzyl group at O5 does not significantly inter-
fere with translation.
To further confirm the presence of the peptide in the
fusion-translation products, the same experiment was re-
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Figure 2. (A) Synthesis of the puromycin mRNA constructs via splint ligation of synthetic oligonucleotides. X is the position where the lesions were
introduced and Y indicates the encoded amino acids, 9 = triethylene glycol linker, P = puromycin. (B) Translation assay: the hybrid template is labeled
with a radioactive phosphate and used in a standard rabbit reticulocyte translation assay. The results are analyzed by PAGE.
peated with a non-labeled mRNA construct and 35S-Met in
the translation mixture. The corresponding fusion transla-
tion product that was then compared with the same product
using the 32P-labeled construct (Figure 5). The 32P-labeled
products were repeatedly diluted until the bands showed
comparable intensity in the gel. As expected in the absence
of the mRNA construct, no band arising from the fusion
product is visible despite the presence of 35S-methionine in
the mixture (Figure 5, lane B). However, for the case of X=
rC, and the O-5-protected 5-HO-rC clear bands are visible
(lanes 1 and 2) that have the same electrophoretic mobility
as the corresponding bands in lanes 1′ and 2′, arising from
the 32P-labeled mRNA construct. When using the unpro-
tected 5-HO-rC lesion (lane 3) two bands are detectable rep-
resenting the full-length and the aborted fusion translation
products. Lanes 4 and 5, finally, show only very faint bands,
in agreement with a lower efficiency of translation. The cor-
responding experiments with the 32P-labeled mRNA con-
struct gave comparable bands, including, of course, those
of the non-translatedmRNA construct that shows the high-
est mobility (lanes 3′–5′). Thus this experiment unambigu-
ously confirms that mRNA–peptide conjugates are formed
during in vitro translation and that truncation is associated
with incomplete peptide synthesis.
Next we decided to extend the assay to the full library
of lesions depicted in Figure 2. For each lesion, the cor-
responding natural base was used as a control. The corre-
sponding mRNA constructs were 32P-labeled and the fu-
sion products compared to the untranslated mRNA con-
structs by PAGE (Figure 6). For all lesions investigated a
new band with intermediate mobility between the mRNA
construct and the fully translated fusion product is visible.
This band can be attributed to aborted ribosomal protein
synthesis at the site of the lesion. The ratio between the
fusion-translation product and the intermediate band de-
pends on the nature of the lesion.
A detailed analysis clearly shows that potentially non-
coding lesions, such as rAS, ε-rA and ε-rC, do completely
abort protein synthesis at the site of the lesion. Indeed, no
fully translated product can be observed, and the only band
that can be detected is the one corresponding to the trun-
cated product. In all the other cases, both the fully trans-
lated and the truncated products were formed in different
ratios. Interestingly, also pyrimidine lesions that show no
obvious change in their coding properties or their confor-
mational preferences around the glycosidic bond such as
5-HO-rU and 5-HO-rC show significant interference with
translation.
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Figure 3. Fusion-translation product of an mRNA construct bearing a rA
at position X (X = A). T = template; F = fusion-translation mixture; a) =
template; b) = fusion product.
Figure 4. Fusion-translation product obtained from the mRNA construct
containing X = rC or X = 5-HO-rC. Column 1: rC; column 2: 5-HO-
rC (5-O-protected); columns 3–5: 5-HO-rC (5-O-deprotected) using dif-
ferently prepared mRNA constructs; column 3: 5-O-deprotected before
translation; column 4: 5-O-deprotected before splint ligation; column 5: 5-
O-deprotected before the splint ligation without subsequent heating. Lane
F: fusion-translation assay products; lane T: mRNA construct as control.
Arrows: a)= template; b)= truncated fusion product; and c)= full-length
fusion product.
DISCUSSION
While there is precedence in the literature on the inhibitory
action of mRNA base-lesions on translation (24,25) there
is a clear lack of understanding the biochemistry behind
Figure 5. Fusion-translation experiment of Figure 4 using 35S-Met and
non-labeled mRNA construct (left, lanes 1–5) or 32P-labeled template and
non-labeledMet (right, lanes 1′–5′). Samples 1–5 are as in Figure 4; B cor-
responds to a fusion-translation experiment with 35S-Met without mRNA
construct. Arrows: a) = template; b) = fusion product; and c) = truncated
fusion products.
these effects in sufficient detail. Herein we report on a ver-
satile method to study the translation of mRNA containing
classical base-lesions on a molecular level. This method is
based on the well-known mRNA display technology and is
characterized by covalently linking a translated peptide to
the corresponding synthetic, mRNA containing the base-
lesions in predefined positions. The reduced size of such
mRNAconstructs allows the use of gel electrophoresis com-
bined with different labeling strategies to evaluate the out-
come of translation. Theoretically this method should also
allow to identify the exact composition of the attached pep-
tide if mass spectrometric tools were used. This, however,
was unsuccessful so far in our hands, most likely due to the
structural complexity of the peptide–oligonucleotide conju-
gates.
We find that all the lesions tested show an important ef-
fect on the translation process (Figure 6). In all cases, an
intermediate band between the template and the full fusion-
translation process appears. Quite interestingly, the same ef-
fect is observed also with 5-HO-rU, although it is known
that this lesion does not have any effect on its coding prop-
erties as evidenced from the duplex stability studies (20,33).
The 5-OH group is quite far away from the hydrogen bond-
ing site and the hydroxyl group does not interfere with them,
nor does it lead to alternative tautomeric forms (34,35). In
comparison with a template containing a natural rU, 5-HO-
rU shows decreased translation efficiency and formation
of a new band in between the template and the full-length
translation band. This species forms the most intense band
and can be explained by stalling ribosomal translation upon
encountering the lesion. The fact that this effect is observed
with 5-HO-rU demonstrates that ribosomal recognition of
the nucleobases is extremely sensitive not only to the coding
edge of the bases.
The investigated base lesions can be classified in two
groups, those that give after translation a mixture of full-
length and truncated product and those leading to a trun-
cated translation product only. In particular ε-rA, ε-rC and
abasic site rAS are belonging to the second class, causing
100% abortion of protein synthesis at the site of lesion. All
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Figure 6. Fusion-translation products of templates bearing a natural base (rA, rC, rG, rU) or a lesion corresponding to the position X. T = mRNA
construct; F = fusion translation. Arrows: a) = template; b) = truncated fusion products; and c) = full-length fusion products.
of them are non-coding lesions since they have no ability to
natural base recognition. They are also known to have the
biggest effects on duplex stability and in reverse transcrip-
tion. The other lesions that maintain the original hydrogen
bonding patterns slow down the translation process, but do
not interrupt it completely. Thus, their impact is less severe
compared to that of the non-coding lesions.
An interesting feature was observed for the 5-HO-rC
(Figure 6). When deprotected 5-HO-rC is used it shows a
behavior similar to the other lesion tested here. On the other
hand, when the translation was carried out using the 5-O-
protected base, an efficiency similar to that of natural rC
could be observed. This points to the fact that the 5-OH
group interacts in the ribosome binding site, most likely via
H-bonding interfering with the readout of the coding edge
of the base.
CONCLUSIONS
We have developed a method that can be used to investi-
gate the effect of RNA lesions on ribosomal translation. So
far, this has only rarely been investigated in the context of
randomly oxidized mRNAs (24,25) but never at high reso-
lution with defined base lesions in preselected positions of a
synthetic mRNA construct. The results obtained here show
that the investigated, commonly known base lesions can be
divided into two groups, the non-coding lesions (etheno le-
sions and abasic site) that interrupt the translation process
quantitatively, and other, less severe lesions that lead to a
mixture of full-length and truncated peptides. The results
obtained for 5-HO-rU and 5-HO-rC show that even remote
base modifications that do not interfere with the base recog-
nition edge lead to inefficient translation.
With the reported synthetic mRNA constructs it is in
principle possible to investigate the effect of base-lesions in
any position of the triplet codon. In addition, the fidelity of
trans-lesion peptide synthesis could be determined in com-
bination with mass spectrometric analysis of the translation
products. With this we aim at understanding the biological
consequences of base-damaged mRNA on translation at a
molecular level.
 at W
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